Effects of oleoyl-estrone with dexfenfluramine, sibutramine or phentermine on overweight rats

European Journal of Pharmacology

Volumn 513, Issue 3, 2005, Pages 243-248

  Ferrer Lorente, Raquel ^a   Cabot, Cristina ^a   Fernández López, José Antonio ^a   Remesar, Xavier ^a   Alemany, Marià ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Dexfenfluramine; Energy balance; Obesity; Oleoyl estrone; Overweight; Phentermine; Sibutramine

Indexed keywords

CHOLESTEROL; DEXFENFLURAMINE; ESTRONE DERIVATIVE; ESTRONE OLEATE; INSULIN; LIPID; PHENTERMINE; SIBUTRAMINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL MODEL; APPETITE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; ENERGY; ENERGY EXPENDITURE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 18144379911     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.02.044     Document Type: Article

References (34)

1. C. Adán, C. Cabot, M. Esteve, M.M. Grasa, R. Massanés, R. Vilà, J. Estruch, J.A. Fernández-López, X. Remesar, and M. Alemany Oleoyl-estrone treatment affects the ponderostat setting differently in lean and obese Zucker rats Int. J. Obesity 22 1999 366 373
2. M. Alemany, J.A. Fernández-López, A. Píetrobelli, M. Granada, M. Foz, and X. Remesar Pérdida de peso en un paciente con obesidad mórbida en tratamiento con oleoil-estrona (Weight loss in a patient with morbid obesity under treatment with oleoyl-estrone) Med. Clin. 121 2003 496 499
3. J.R. Arch The contribution of increased thermogenesis to the effect of anorectic drugs on body composition in mice Am. J. Clin. Nutr. 34 1981 2763 2769
4. F. Balada, D. Sanchis, J. Virgili, M.M. Grasa, C. Monserrat, J.A. Fernández-López, X. Remesar, and M. Alemany Effect of the slimming agent oleoyl-estrone in liposomes (Merlin-2) on the body weight of rats fed a cafeteria diet Arch. Physiol. Biochem. 105 1997 487 495
5. A.C. Beynen, D. Dekker, B.L. Gundlach, and G. Vantintelen Body-composition of obese rats fed the anorectic drug dexfenfluramine Nutr. Rep. Int. 33 1986 491 497
6. J.E. Blundell, and AJ. Hill Dexfenfluramine and appetite in humans Int. J. Obesity 16 1992 S51 S59
7. E. Bonora, F. Saggiani, G. Targher, M.B. Zenere, M. Alberiche, T. Monauni, R.C. Bonadonna, and M. Muggeo Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity Diabetes Care 23 2000 57 63
8. G.A. Bray, and F.L. Greenway Current and potential drugs for treatment of obesity Endocr. Rev. 20 1999 805 875
9. C. Cabot, M.M. Grasa, C. Adán, J. Pérez-Clausell, J. Virgili, J. Estruch, J.A. Fernández-López, X. Remesar, and M. Alemany Oleoyl-estrone does not alter hypothalamic neuropeptide Y Peptides 19 1998 1631 1635
10. C. Cabot, M.M. Grasa, J. Estruch, J.A. Fernández-López, X. Remesar, and M. Alemany Zucker obese rats are insensitive to the CRH-increasing effect of oleoyl-estrone Brain Res. Bull. 46 1998 529 534
11. J.A. Fernández-López, X. Remesar, M. Foz, and M. Alemany Pharmacological approaches for the treatment of obesity Drugs 62 2002 915 944
12. N. Finer Sibutramine: its mode of action and efficacy Int. J. Obesity 26 2002 S29 S33
13. N. Finer, D. Craddock, R. Lavielle, and H. Keen Prolonged weight-loss with dexfenfluramine treatment in obese patients Diabetes Metab. 13 1987 598 602
14. J. Folch, M. Lees, and G.H. Sloane-Stanley A simple method for the isolation and purification of total lipids from animal tissues J. Biol. Chem. 232 1957 497 509
15. M.M. Grasa, C. Cabot, M. Esteve, P. Yubero, R.M. Massanés, M. Blay, R. Vilà, J. López-Martí, J.A. Fernández- López, X. Remesar, and M. Alemany Daily oral oleoyl-estrone gavage induces a dose-dependent loss of fat in Wistar rats Obes. Res. 9 2001 202 209
16. M.M. Grasa, M. Esteve, R.M. Massanés, P. Yubero, M. Blay, J. López-Martí, C. Cabot, R. Vilà, J.A. Fernández- López, X. Remesar, and M. Alemany Oral gavage of oleoyl-estrone has a stronger effect on body weight in male obese Zucker rats than in female Diabetes Obes. Metab. 3 2001 203 208
17. D.L. Hansen, S. Toubro, M.J. Stock, I.A. Macdonald, and A. Astrup The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction Int. J. Obesity 23 1999 1016 1024
18. D.J. Heal, S. Aspley, M.R. Prow, H.C. Jackson, K.F. Martin, and S.C. Cheetham Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine Int. J. Obesity 22 Suppl. 1 1998 S18 S28
19. W.P.T. James, A. Astrup, N. Finer, J. Hilsted, P. Kopelman, S. Rössner, W.H.M. Saris, and L. van Gaal Effect of sibutramine on weight maintenance after weight loss: a randomised trial Lancet 356 2000 2119 2125
20. J.G. Jollis, C.K. Landolfo, J. Kisslo, G.D. Constantine, K.D. Davis, and T. Ryan Fenfluramine and phentermine and cardiovascular findings-effect of treatment duration on prevalence of valve abnormalities Circulation 101 2000 2071 2077
21. H.A. Mancini Treatment of obesity: an update on anti-obesity medications Obes. Rev. 4 2003 25 42
22. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Teacher, and R.C. Turner Homeostasis model assessment: insulin resistance and B cell function from fasting plasma glucose and insulin concentration in man Diabetologia 28 1985 412 419
23. J. Mayer Glucostatic mechanism of regulation of food intake N. Engl. J. Med. 249 1953 13 16
24. X. Remesar, J.A. Fernández-López, M.T. Blay, P. Savall, A. Salas, M. Díaz-Silva, M. Esteve, M.M. Grasa, and M. Alemany Effect of oral oleoyl-estrone on adipose tissue composition in male rats Int. J. Obesity 26 2002 1092 1102
25. S. Rich, A. Shillington, and V. McLaughlin Comparison of survival in patients with pulmonary hypertension associated with fenfluramine to patients with primary pulmonary hypertension Am. J. Cardiol. 92 2003 1366 1368
26. D.H. Ryan Clinical use of sibutramine Drugs Today 40 2004 41 54
27. M. Sachdev, W.C. Miller, T. Ryan, and J.G. Jolis Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies Am. Heart J. 144 2002 1065 1073
28. R. Samanin, and S. Garattini Neurochemical mechanism of action of anorectic drugs Pharmacol. Toxicol. 73 1993 63 68
29. D. Sanchis, F. Balada, M.M. Grasa, J. Virgili, J. Peinado, C. Monserrat, J.A. Fernández-López, X. Remesar, and M. Alemany Oleoyl-estrone induces the loss of body fat in rats Int. J. Obesity 20 1990 588 594
30. P. Turner Dexfenfluramine. Its place in weight control Drugs 39 1990 53 62
31. L.F. van Gaal, M.A. Wauters, F.W. Peiffer, and I.H. de Leeuw Sibutramine and fat distribution: is there a role for pharmacotherapy in abdominal/visceral fat reduction? Int J. Obesity 22 suppl. 1 1998 S38 S40
32. J.P. Voigt, R. Schade, H. Fink, and H. Hörtnagl Role of 5-HT1A receptors in the control of food intake in obese Zucker rats of different ages Pharmacol. Biochem. Behav. 72 2002 403 409
33. P.J. Wellman, and T.J. Maher Synergistic interactions between fenfluramine and phentermine Int. J. Obesity 23 1999 723 732
34. L. Zychlinski, and M.R. Montgomery Alterations in monoamine oxidase activity after single and repeated exposure of rats to chlorphenthermine Toxicol. Lett. 22 1984 133 138